[go: up one dir, main page]

SE0301884D0 - New use III - Google Patents

New use III

Info

Publication number
SE0301884D0
SE0301884D0 SE0301884A SE0301884A SE0301884D0 SE 0301884 D0 SE0301884 D0 SE 0301884D0 SE 0301884 A SE0301884 A SE 0301884A SE 0301884 A SE0301884 A SE 0301884A SE 0301884 D0 SE0301884 D0 SE 0301884D0
Authority
SE
Sweden
Prior art keywords
new use
use iii
wound healing
hsd1
inhibitor
Prior art date
Application number
SE0301884A
Other languages
Swedish (sv)
Inventor
Cecilia Nilsson
Catrine Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0301884A priority Critical patent/SE0301884D0/en
Publication of SE0301884D0 publication Critical patent/SE0301884D0/en
Priority to PCT/SE2004/000957 priority patent/WO2004112785A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a method for promoting wound healing, said method comprising administering to a mammal, including man, in need of such promotion an effective amount of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 (11b-HSD1), said 11b-HSD1 inhibitor having the formula (I) wherein T, E, L, R6, R7, R8 and R9 are as defined in the specification. These compounds may also be used in the manufacture of a medicament for promoting wound healing.
SE0301884A 2003-06-25 2003-06-25 New use III SE0301884D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0301884A SE0301884D0 (en) 2003-06-25 2003-06-25 New use III
PCT/SE2004/000957 WO2004112785A1 (en) 2003-06-25 2004-06-16 New use iii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301884A SE0301884D0 (en) 2003-06-25 2003-06-25 New use III

Publications (1)

Publication Number Publication Date
SE0301884D0 true SE0301884D0 (en) 2003-06-25

Family

ID=27656619

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301884A SE0301884D0 (en) 2003-06-25 2003-06-25 New use III

Country Status (2)

Country Link
SE (1) SE0301884D0 (en)
WO (1) WO2004112785A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI352700B (en) 2004-05-24 2011-11-21 Amgen Inc Inhibitors of 11-beta-hydroxy steroid dehydrogenas
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
CN103073460B (en) 2004-10-14 2015-09-09 Abbvie德国有限责任两合公司 Be applicable to treat the aromatic substance that the arylsulfonyl ylmethyl of the disease responded for the adjustment of dopamine D 3 receptor or aryl sulfonic acid amides replace
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
US8541592B2 (en) 2005-11-22 2013-09-24 Amgen Inc. Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives
EP3821892A1 (en) 2019-11-12 2021-05-19 University of Leeds (s)-2-(1-(5-(cyclohexylcarbamoyl)-6-(propylthio)pyridin-2-yl)piperidin-3-yl) acetic acid for use in treating wounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10639A (en) * 1967-07-17 1977-07-22 Research Corp Method of treatment and composition containing silver sulfadiazine
EE9700251A (en) * 1995-04-04 1998-04-15 Texas Biotechnology Corporation Thienyl, furyl, pyrrolyl and biphenylsulfonamides and their derivatives, which modulate endothelin activity
DE69718038D1 (en) * 1996-10-16 2003-01-30 American Cyanamid Co PRODUCTION AND USE OF ORTHO-SULFONAMIDO-HETEROARYLHYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS
SE0001899D0 (en) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds

Also Published As

Publication number Publication date
WO2004112785A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
SE0301882D0 (en) New use I
SE0301886D0 (en) New use V
SE0301888D0 (en) New use VII
CY1109242T1 (en) THERAPEUTIC AGENTS USEFUL FOR PAIN TREATMENT
SE0101387D0 (en) Novel compounds
EA201000563A1 (en) TRIAZOLPYRIDINE INHIBITORS 11-BETA-HYDROXYSTEROID - DEHYDROGENASE TYPE I
CY1111177T1 (en) FAINOTHEASINE UNION FOR INJURY HEALING
DE602006010442D1 (en) USE OF BENZO-CONDENSED HETEROCYCLIC SULPHAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN
ATE373474T1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE TREATMENT OF DEPRESSION
ATE384058T1 (en) THIAZOLE DERIVATIVES
CY1109763T1 (en) MATERIALS AND METHOD FOR TREATMENT OF CELLULAR DISORDERS
ATE495187T1 (en) DALDA ANALOGUES AND THEIR USE
MXPA05000765A (en) 5-aryltetrazole compounds, compositions thereof, and uses therefor.
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
DK1458393T3 (en) Substituted diketopiperazines as oxytocin antagonists
ATE516027T1 (en) ORAZAMID OROTAT TO PREVENT LIVER DAMAGE
ECSP055844A (en) NEW TRICYCLE COMPOUNDS
DE60329326D1 (en) TACE INHIBITORS
EA200601249A1 (en) PIPERASINS, SUITABLE FOR THE TREATMENT OF PAIN
SE0301883D0 (en) New use II
SE0301884D0 (en) New use III
SE0301885D0 (en) New use IV
SE0004101D0 (en) New use
SE0002739D0 (en) New use